Osteosarcoma Lung Metastases Detection and Principles of Multimodal Therapy

Part of the Cancer Treatment and Research book series (CTAR, volume 152)


The management of pulmonary metastases poses a challenge to the multidisciplinary team involved in the treatment of osteosarcoma. A postal survey on the management of pulmonary metastases in osteosarcoma involving 17 representatives from international study groups and selected institutions was performed in which a response rate of 94% was achieved. The results showed uniform approaches in areas like the imaging methods used for initial staging and the use of manual exploration with thoracotomy. However, it demonstrated diverse practices regarding exploration of the unaffected site in unilateral pulmonary disease, and the approach to lesions disappearing under chemotherapy. Furthermore, agreement on the size of a lesion considered to distinguish between benign and of metastatic origin, varied. Based on the survey and a review of the current literature, detection methods and principles of multimodal therapy will be discussed. Prognostic factors in synchronous and metachronous pulmonary metastases and their implications for a multimodal therapy is also presented.


Pulmonary Metastasis Line Chemotherapy Aggressive Surgical Approach Subsequent Relapse Manual Exploration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Kager L, Zoubek A, Pötschger U, et al. Primary metastatic osteosarcoma: Presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2003;21:2011-2018.CrossRefPubMedGoogle Scholar
  2. 2.
    Bacci G, Briccoli A, Rocca M, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: Recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann Oncol. 2003;14:1126-1134.CrossRefPubMedGoogle Scholar
  3. 3.
    Kempf-Bielack B, Bielack SS, Jürgens H, et al. Osteosarcoma relapse after combined modality therapy: An analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol. 2005;23:559-568.CrossRefPubMedGoogle Scholar
  4. 4.
    Chi SN, Conklin LS, Qin J, et al. The patterns of relapse in osteosarcoma: The Memorial Sloan-Kettering experience. Pediatr Blood Cancer. 2004;42:46-51.CrossRefPubMedGoogle Scholar
  5. 5.
    Bielack SS Kempf-Bielack B, Branscheid D, et al. Second and subsequent recurrences of osteosarcoma: Presentation, treatment, and outcomes of 249 consecutive Cooperative Osteosarcoma Study Group (COSS) patients. J Clin Oncol 2009; 27:557-65.Google Scholar
  6. 6.
    Bacci G, Briccoli A, Longhi A, et al. Treatment and outcome of recurrent osteosarcoma: Experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy. Acta Oncol. 2005;44:748-755.CrossRefPubMedGoogle Scholar
  7. 7.
    Pastorino U, Gasparini M, Tavecchio L, et al. The contribution of salvage surgery to the management of childhood osteosarcoma. J Clin Oncol. 1991;9:1357-1362.PubMedGoogle Scholar
  8. 8.
    Kaste SC, Pratt CB, Cain AM, et al. Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: Imaging features. Cancer. 1999;86(8):1602-1608.CrossRefPubMedGoogle Scholar
  9. 9.
    McCarville MB, Kaste SC, Cain AM, et al. Prognostic factors and imaging patterns of recurrent pulmonary nodules after thoracotomy in children with osteosarcoma. Cancer. 2001;91(6):1170-1176.CrossRefPubMedGoogle Scholar
  10. 10.
    Hawkins DS, Arndt CA. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy. Cancer. 2003;98:2447-2456.CrossRefPubMedGoogle Scholar
  11. 11.
    Saeter G, Høie J, Stenwig AE, et al. Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival. Cancer. 1995;75:1084-1093.CrossRefPubMedGoogle Scholar
  12. 12.
    Harris MB, Gieser P, Goorin AM, et al. Treatment of metastatic osteosarcoma at diagnosis: A Pediatric Oncology Group Study. J Clin Oncol. 1998;16:3641-3648.PubMedGoogle Scholar
  13. 13.
    Picci P, Vanel D, Briccoli A, et al. Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. Ann Oncol. 2001;12:1601-1604.CrossRefPubMedGoogle Scholar
  14. 14.
    Kayton ML, Huvos AG, Casher J, et al. Computer tomographic scan of chest underestimates the number of metastatic lesions in osteosarcoma. J Ped Surg. 2006;41:200-206.CrossRefGoogle Scholar
  15. 15.
    Su WT, Chewning J, Abramson S, et al. Surgical management and outcome of osteosarcoma patients with unilateral pulmonary metastases. J Pediatr Surg. 2004;39:418-423.CrossRefPubMedGoogle Scholar
  16. 16.
    Brady AP, Ennis JT. The scintigraphic detection of ossific mediastinal and pulmonary metastases in osteosarcoma. Br J Radiol. 1990;63:978-980.CrossRefPubMedGoogle Scholar
  17. 17.
    Garcia J, Kim E, Wong F, et al. Comparison of Fluorine – 18-FDG PET and Technetium-99 m-MIBI SPECT in Evaluation of Musculoskeletal Sarcomas. J Nucl Med. 1996;37:1476-1479.PubMedGoogle Scholar
  18. 18.
    Arush M, Israel O, Postovsky S, et al. PET/CT with 18FDG in the dectection of local recurrence and distant metastases in Pediatric Saracoma. Ped Blood Cancer. 2007;49:901-905.CrossRefGoogle Scholar
  19. 19.
    Iagaru A, Chawla S, Menendez L, et al. 18-FDG-PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas. Nucl Med Commun. 2006;27:795-802.CrossRefPubMedGoogle Scholar
  20. 20.
    Franzius C, Daldrup-Link HE, Sciuk J, et al. FDG-PET for pulmonary metastases from malignant primary bone tumors: Comparison with spiral CT. Ann Onc. 2001;12:479-486.CrossRefGoogle Scholar
  21. 21.
    Völker T, Denecke T, Steffen I, et al. Positron emission tomography for staging of pediatric sarcoma patients: Results of a prospective multicenter trial. J Clin Oncol. 2007;25:5435-5441.CrossRefPubMedGoogle Scholar
  22. 22.
    Franzius C, Daldrup-Link HE, Wagner-Bohn A, Sciuk J, et al. FDG-PET for detection of recurrences from malignant primary bone tumors: Comparison with conventional imaging. Ann Oncol. 2002;13(1):157-160.CrossRefPubMedGoogle Scholar
  23. 23.
    Soret M, Bacharach S, Buvat I. Partial volume effect in PET tumor imaging. J Nucl Med. 2007;48:932-945.CrossRefPubMedGoogle Scholar
  24. 24.
    Meyers PA, Heller G, Healey JH, et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol. 1993;11:449-453.PubMedGoogle Scholar
  25. 25.
    Tsuchiya H, Kanazawa Y, Abdel-Wanis ME, et al. Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: The Japanese Musculoskeletal Oncology Group study. J Clin Oncol. 2002;20:3470-3477.CrossRefPubMedGoogle Scholar
  26. 26.
    Daw NC, Billups CA, Rodriguez-Galindo C, et al. Metastatic osteosarcoma. Cancer. 2006;106:403-412.CrossRefPubMedGoogle Scholar
  27. 27.
    Rusch VW. Surgical techniques for pulmonary metastasectomy. Sem Thoracic Cardiovasc Surg. 2002;14:4-9.CrossRefGoogle Scholar
  28. 28.
    Parsons AM, Ennis EK, Yankaskas BC, Parker LA Jr, Hyslop WB, Detterbeck FC. Helical computed tomography inaccuracy in the detection of pulmonary metastases: Can it be improved. Ann Thorac Surg. 2007;84(6):1830-1836.CrossRefPubMedGoogle Scholar
  29. 29.
    La Quaglia MP. Osteosarcoma. Specific tumor management and results. Chest Surg Clin N Am. 1998;8:77-95.PubMedGoogle Scholar
  30. 30.
    Picci P. Osteosarcoma (osteogenic sarcoma). Orphanet J Rare Dis. 2007;2:6.CrossRefPubMedGoogle Scholar
  31. 31.
    McCormack PM, Bains MS, Begg CB, et al. Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: Results of a prospective trial. Ann Thorac Surg. 1996;62(1):213-216.CrossRefPubMedGoogle Scholar
  32. 32.
    Castagnetti M, Delarue A, Gentet JC. Optimizing the surgical management of lung nodules in children with osteosarcoma: Thoracoscopy for biopsies, thoracotomy for resections. Surg Endosc. 2004;18:1668-1671.PubMedGoogle Scholar
  33. 33.
    Sartorelli KH, Partrick D, Meagher DP. Port-site recurrence after thoracoscopic resection of pulmonary metastasis owing to osteogenic sarcoma. J Pediatr Surg. 1996;31:1443-1444.CrossRefPubMedGoogle Scholar
  34. 34.
    Goorin AM, Delorey MJ, Lack EE, et al. Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: Analysis of 32 patients. J Clin Oncol. 1984;2(5):425-431.PubMedGoogle Scholar
  35. 35.
    Briccoli A, Rocca M, Salone M, et al. Resection of recurrent pulmonary metastases in patients with osteosarcoma. Cancer. 2005;104:1721-1725.CrossRefPubMedGoogle Scholar
  36. 36.
    Bacci G, Mercuri M, Briccoli A, et al. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions. Cancer. 1997;79:245-254.CrossRefPubMedGoogle Scholar
  37. 37.
    Mialou V, Philip T, Kalifa C, et al. Metastatic osteosarcoma at diagnosis: Prognostic factors and long-term outcome – the French pediatric experience. Cancer. 2005;104:1100-1109.CrossRefPubMedGoogle Scholar
  38. 38.
    Ward WG, Mikaelian K, Dorey F, et al. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol. 1994;12:1849-1858.PubMedGoogle Scholar
  39. 39.
    Goorin AM, Harris MB, Bernstein M, et al. Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: A pediatric oncology group trial. J Clin Oncol. 2002;20:426-433.CrossRefPubMedGoogle Scholar
  40. 40.
    Marina NM, Pratt CB, Rao BN, et al. Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis. Cancer. 1992;70:2722-2727.CrossRefPubMedGoogle Scholar
  41. 41.
    Bacci G, Ruggieri P, Bertoni F, et al. Local and systemic control for osteosarcoma of the extremity treated with neoadjuvant chemotherapy and limb salvage surgery: The Rizzoli experience. Oncol Rep. 2000;7:1129-1133.PubMedGoogle Scholar
  42. 42.
    Bacci G, Ferrari S, Longhi A, et al. High-grade osteosarcoma of the extremity: Differences between localized and metastatic tumors at presentation. J Pediatr Hematol Oncol. 2002;24:27-30.CrossRefPubMedGoogle Scholar
  43. 43.
    Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776-790.CrossRefPubMedGoogle Scholar
  44. 44.
    Bielack SS, Machatschek JN, Flege S, et al. Delaying surgery with chemotherapy for osteosarcoma of the extremities. Expert Opin Pharmacother. 2004;5:1243-1256.CrossRefPubMedGoogle Scholar
  45. 45.
    Fagioli F, Aglietta M, Tienghi A, et al. High-dose chemotherapy in the treatment of relapsed osteosarcoma: An Italian Sarcoma Group Study. J Clin Oncol. 2002;20:2150-2156.CrossRefPubMedGoogle Scholar
  46. 46.
    Tabone MD, Kalifa C, Rodary C, et al. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. J Clin Oncol. 1994;12:2614-2620.PubMedGoogle Scholar
  47. 47.
    Crompton BD, Goldsby RE, Weinberg VK, et al. Survival after recurrence of osteosarcoma: A 20-year experience at a single institution. Pediatr Blood Cancer. 2006;47:255-259.CrossRefPubMedGoogle Scholar
  48. 48.
    Chou AJ, Merola PR, Wexler LH, et al. Treatment of osteosarcoma at first recurrence after contemporary therapy: The Memorial Sloan-Kettering Cancer Center experience. Cancer. 2005;104:2214-2221.CrossRefPubMedGoogle Scholar
  49. 49.
    Goorin AM, Shuster JJ, Baker A, et al. Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: Results from the multiinstitutional osteosarcoma study. J Clin Oncol. 1991;9:600-605.PubMedGoogle Scholar
  50. 50.
    Antunes M, Bernardo J, Salete M, et al. Excision of pulmonary metastases of osteogenic sarcoma of the limbs. Eur J Cardiothorac Surg. 1999;15:592-596.CrossRefPubMedGoogle Scholar
  51. 51.
    Roth JA, Putnam JB Jr, Wesley MN, et al. Differing determinants of prognosis following resection of pulmonary metastases from osteogenic and soft tissue sarcoma patients. Cancer. 1985;55:1361-1366.CrossRefPubMedGoogle Scholar
  52. 52.
    Han MT, Telander RL, Pairolero PC, et al. Aggressive thoracotomy for pulmonary metastatic osteogenic sarcoma in children and young adolescents. J Pediatr Surg. 1981;16:928-933.CrossRefPubMedGoogle Scholar
  53. 53.
    Al-Jilaihawi AN, Bullimore J, Mott M, et al. Combined chemotherapy and surgery for pulmonary metastases from osteogenic sarcoma. Results of 10 years experience. Eur J Cardiothorac Surg. 1988;2:37-42.CrossRefPubMedGoogle Scholar
  54. 54.
    Snyder CL, Saltzman DA, Ferrell KL, et al. A new approach to the resection of pulmonary osteosarcoma metastases. Results of aggressive metastasectomy. Clin Orthop Relat Res. 1991;270:247-253.PubMedGoogle Scholar
  55. 55.
    Heij HA, Vos A, de Kraker J, et al. Prognostic factors in surgery for pulmonary metastases in children. Surgery. 1994;115:687-693.PubMedGoogle Scholar
  56. 56.
    Temeck BK, Wexler LH, Steinberg SM, et al. Metastasectomy for sarcomatous pediatric histologies: Results and prognostic factors. Ann Thorac Surg. 1995;59:1385-1389.CrossRefPubMedGoogle Scholar
  57. 57.
    Meyer WH, Schell MJ, Kumar AP, et al. Thoracotomy for pulmonary metastatic osteosarcoma. An analysis of prognostic indicators of survival. Cancer. 1987;59:374-379.CrossRefPubMedGoogle Scholar
  58. 58.
    Ferrari S, Briccoli A, Mercuri M, et al. Postrelapse survival in osteosarcoma of the extremities: Prognostic factors for long-term survival. J Clin Oncol. 2003;21:710-715.CrossRefPubMedGoogle Scholar
  59. 59.
    Duffaud F, Digue L, Mercier C, et al. Recurrences following primary osteosarcoma in adolescents and adults previously treated with chemotherapy. Eur J Cancer. 2003;39:2050-2057.CrossRefPubMedGoogle Scholar
  60. 60.
    Sauerbrey A, Bielack S, Kempf-Bielack B, et al. High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma. Bone Marrow Transplant. 2001;27:933-937.CrossRefPubMedGoogle Scholar
  61. 61.
    Janinis J, McTiernan A, Driver D, et al. A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma. Ann Onc. 2002;13:1935-1944.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Pediatrics 5 (Oncology, Haematology, Immunology)Klinikum Stuttgart, OlgahospitalStuttgartGermany

Personalised recommendations